GlassScriptPhysician profile
Andrew S Binder
NPI 1649367426
$149,182.50
in general payments reported to CMS, 2019-2025
12 companies · $509 in 2025
The $509 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $9,854 · 2021: $23K · 2022: $35K · 2023: $28K · 2024: $13K · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Consulting Fee: $7,875 · Travel and Lodging: $4,537 · Food and Beverage: $2,468 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,605.00 |
| Consulting Fee | $7,875.00 |
| Travel and Lodging | $4,536.85 |
| Food and Beverage | $2,467.55 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $126,567.89 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13,352.50 | 2021 | |
| Axsome Therapeutics, INC. | $8,269.67 | 2022-2025 | Sunosi |
| Harmony Biosciences LLC | $600.04 | 2020-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $152.69 | 2023-2025 | Lumryz |
| Advanced Respiratory, INC | $74.03 | 2019 | |
| Smith+Nephew, INC. | $44.33 | 2023 | Stravix |
| Novo Nordisk INC | $34.30 | 2022-2023 | |
| Arbor Pharmaceuticals, INC. | $23.95 | 2019 | |
| Ethicon US, LLC | $21.83 | 2023 | Linx Reflux Management System |
| Eisai INC. | $20.69 | 2021 | |
| Inspire Medical Systems, INC. | $20.58 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Binder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.